

Cover Story
Capitol HillFree
By Matthew Bin Han Ong
After taking eight months to respond to a House committee’s questions about policies on handling of sexual misconduct cases, a letter from NIH has provided answers that critics describe as vague and inadequate.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Trump’s tariffs on generic drugs are “another wrinkle in an already unstable system”
- NCAB asks for help from administration as NCI deals with deluge of grant applications
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home

















